Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.86 USD
Change Today +0.06 / 0.68%
Volume 24.8K
BIOA On Other Exchanges
Symbol
Exchange
New York
Berlin
EN Paris
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

bioamber inc (BIOA) Key Developments

BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

BioAmber Inc. announced unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. Revenues for the year ended December 31, 2014 decreased to $1.5 million from $2.7 million for the same period in 2013. Sales volume in 2014 was slightly higher than in 2013, but was offset by a decrease in the average sales price that resulted from customers seeking pricing more in line with the prices BioAmber has contractually committed to for future Sarnia supply. The company continues to manage sales in an effort to preserve its bio-succinic acid inventory levels in advance of the Sarnia plant start-up. The company recorded a net loss attributable to BioAmber Inc. shareholders of $46.4 million, or a loss of $2.32 per share, for the year ended December 31, 2014, as compared to a net loss of $33.2 million, or a loss of $2.13 per share, for the same period in 2013. The adjusted net loss attributable to BioAmber Inc. Shareholders for the year ended December 31, 2014 was $34.7 million, or a loss of $1.74 per share, compared to an adjusted net loss attributable to BioAmber Inc. Shareholders of $33.6 million, or a loss of $2.16 per share, for the same period in 2013. Operating loss was $35.205 million against $41.180 million a year ago. Net cash used in operating activities was $22.453 million against $27.525 million a year ago. Acquisition of property and equipment was $85.014 million against $12.788 million a year ago. Loss before income taxes was $47.222 million against $33.688 million a year ago. For the quarter, the company reported product sales of $0.308 million, operating loss of $9.038 million and net loss attributable to shareholders of $4.357 million or $0.20 per basic share compared to product sales of $0.439 million, operating loss of $7.810 million and net loss attributable to shareholders of $7.828 million or $0.42 per basic share a year ago period. Net cash used in operating activities was $12.247 million against $4.815 million a year ago. Acquisition of property and equipment was $25.540 million against $8.181 million a year ago. Adjusted Net Loss attributable to company shareholders was $10,378 million or $0.48 per basic share against $8.388 million or $0.45 per basic share a year ago. Loss before income taxes was $4.710 million against $7.950 million a year ago.

BioAmber Inc. to Report Q4, 2014 Results on Mar 12, 2015

BioAmber Inc. announced that they will report Q4, 2014 results at 4:30 PM, US Eastern Standard Time on Mar 12, 2015

BioAmber Inc., Q4 2014 Earnings Call, Mar 12, 2015

BioAmber Inc., Q4 2014 Earnings Call, Mar 12, 2015

BioAmber Inc. Presents at 27th Annual ROTH Conference, Mar-09-2015 04:00 PM

BioAmber Inc. Presents at 27th Annual ROTH Conference, Mar-09-2015 04:00 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States.

BioAmber Inc. Announces Management Changes

BioAmber Inc. announced that chief financial officer Andrew Ashworth retired on December 31, 2014 and Francois Laurin has been hired to succeed Andrew as the company's chief financial officer. BioAmber also announced that long-time board member Denis Lucquin had resigned effective December 31, 2014. Andrew will continue in an advisory role to the company in the first half of 2015 to ensure a smooth transition. Francois was most recently the CFO of Alderon Iron Ore Corp. Denis Lucquin is the Managing Partner of Sofinnova Partners. Denis' decision to resign was due to his firm's policy to step down from board memberships following initial public offerings.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOA:US $8.86 USD +0.06

BIOA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIOA.
View Industry Companies
 

Industry Analysis

BIOA

Industry Average

Valuation BIOA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 125.3x
Price/Book 3.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 52.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOAMBER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.